Studies on human AD brain have found CB1 expression on neurons reduced (53) or unchanged (54); in contrast, CB2 expression is dramatically up-regulated, particularly in the microglial cells surrounding b-amyloid plaques (53, 54). Here, CNR2 is linked to Alzheimer disease.